Article History
First Online: 28 June 2018
Competing interests
: T.v.d.G. works in a full-time position for AstraZeneca. AstraZeneca had no influence on any aspect of this manuscript. H.G.L. reports that he is the past chairman of Dutch Medicines Evaluation Board and past member of the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), and scientific director of the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation. This centre accepts no direct funding or donations from the pharmaceutical industry or other private parties. T.P. declares no competing interests.